<DOC>
	<DOCNO>NCT02816047</DOCNO>
	<brief_summary>Background : The wearable cardioverter defibrillator ( WCD ) establish treatment option patient high risk ventricular tachycardia / ventricular fibrillation ( VT/VF ) , either risk may temporarily present , patient high risk sudden cardiac death ( SCD ) VT/VF implantable cardioverter defibrillator ( ICD currently possible reason ( infection , recent MI &lt; 40days , recent PCI/CABG &lt; 3months etc. ) . Methods : Comprehensive registry include patient Austria receive WCD 2010-2016 .</brief_summary>
	<brief_title>Austrian Wearable Cardioverter Defibrillator Registry</brief_title>
	<detailed_description>Observational study describe WCD indication , event rate , inappropriate shock rate follow ( include ICD rate , shock rate , morbidity mortality ) Austrian WCD patient</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<mesh_term>Death , Sudden</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>patient , prescribe WCD austrian center</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>wearable cardioverter defibrillator</keyword>
	<keyword>LifeVest</keyword>
	<keyword>sudden death</keyword>
	<keyword>defibrillator</keyword>
</DOC>